As a result, the released Zn2+ could not only inactivate mitochondria in tumor cells by inhibiting oxidative respiration from inducing mitochondrial swelling and loss of membrane potential but also destroy the antioxidant system of tumor cells via inhibiting the activities of thioredoxin reductase and GSH reductase (Figure 7D). Here, PRDX5 is linked to neoplasm.